Marker Therapeutics (MRKR) Retained Earnings (2010 - 2026)
Marker Therapeutics (MRKR) reported Retained Earnings of -$462.4 million for Q1 2026, down 2.41% year-over-year from -$473.8 million in Q1 2025, and down 0.69% quarter-over-quarter from -$459.2 million in Q4 2025.
Marker Therapeutics (MRKR) Retained Earnings (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has 17 years of Retained Earnings data on file, last reported at -$462.4 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$462.4 million, down 2.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$462.4 million (down 2.41% YoY), and the FY2025 annual result was -$459.2 million, down 2.72% from the prior year.
- Retained Earnings eased to -$462.4 million in Q1 2026 per MRKR's latest filing, from -$459.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$408.0 million in Q1 2022 and troughed at -$462.4 million in Q1 2026.
- A 5-year average of -$439.2 million and a median of -$438.7 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings fell 11.78% in 2022, then dropped 1.31% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$428.0 million in 2022, then declined by 1.92% to -$436.3 million in 2023, then decreased by 2.46% to -$447.0 million in 2024, then dropped by 2.72% to -$459.2 million in 2025, then slipped by 0.69% to -$462.4 million in 2026.
- Business Quant data shows MRKR's Retained Earnings at -$462.4 million in Q1 2026, -$459.2 million in Q4 2025, and -$457.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | -462.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -462.36 Mn |
| Dec 31, 2025 | -459.18 Mn |
| Sep 30, 2025 | -457.48 Mn |
| Jun 30, 2025 | -455.48 Mn |
| Mar 31, 2025 | -451.46 Mn |
| Dec 31, 2024 | -447.02 Mn |
| Sep 30, 2024 | -443.18 Mn |
| Jun 30, 2024 | -440.87 Mn |
| Mar 31, 2024 | -438.68 Mn |
| Dec 31, 2023 | -436.29 Mn |
| Sep 30, 2023 | -433.48 Mn |
| Jun 30, 2023 | -430.50 Mn |
| Mar 31, 2023 | -433.02 Mn |
| Dec 31, 2022 | -428.05 Mn |
| Sep 30, 2022 | -424.19 Mn |
| Jun 30, 2022 | -417.27 Mn |
| Mar 31, 2022 | -408.03 Mn |
| Dec 31, 2021 | -398.12 Mn |
| Sep 30, 2021 | -388.36 Mn |
| Jun 30, 2021 | -375.93 Mn |